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Abstract: 
Laccase-catalyzed degradation of a broad spectrum of trace organic contaminants (TrOCs) by a 
membrane distillation (MD)-enzymatic membrane bioreactor (EMBR) was investigated. The MD 
component effectively retained TrOCs (94-99%) in the EMBR, facilitating their continuous biocatalytic 
degradation. Notably, the extent of TrOC degradation was strongly influenced by their molecular 
properties. A significant degradation (above 90%) of TrOCs containing strong electron donating 
functional groups (e.g., hydroxyl and amine groups) was achieved, while a moderate removal was 
observed for TrOCs containing electron withdrawing functional groups (e.g., amide and halogen groups).  
The addition of two redox-mediators, namely syringaldehyde and violuric acid, further improved TrOC 
degradation. However, a mixture of redox-mediators showed a reduced performance for a few 
pharmaceuticals such as primidone, carbamazepine and ibuprofen. Mediator addition increased the 
toxicity of the media in the enzymatic bioreactor, but the membrane permeate (i.e., final effluent) was 
non-toxic, suggesting an added advantage of coupling MD with EMBR.  
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1. Introduction 
Membrane distillation (MD) is a low temperature distillation process in contrast to conventional 
distillation processes such as fractional or steam distillation. It essentially relies on the transport of water 
in the vapor phase from a feed solution through a microporous hydrophobic membrane to the permeate or 
distillate. Among different MD configurations, direct contact membrane distillation (DCMD) has been 
predominantly studied due to the ease of its operation (Alkhudhiri et al., 2012; Curcio & Drioli, 2005). In 
DCMD, the temperature of the feed solution is maintained at 15-20 ºC higher than the permeate to create 
an adequate vapor pressure difference, which allows water to pass through a microporous membrane in 
vapor form via diffusion (Alkhudhiri et al., 2012; Duong et al., 2017). Since mass transfer occurs in 
gaseous phase, MD can theoretically achieve complete rejection of all non-volatile compounds (Martinetti 
et al., 2009; Wijekoon et al., 2014a).  
Due to efficient separation efficiency, low fouling propensity and potentially low energy requirement 
(subject to the availability of low grade heat), stand-alone MD has been studied for applications such as 
protein recovery in dairy processing (Hausmann et al., 2013), treatment of industrial (Khaing et al., 2010) 
and municipal wastewater (Phattaranawik et al., 2008; Wijekoon et al., 2014b), as well as for the removal 
of trace organic contaminant (TrOCs), such as pharmaceuticals and personal care products, pesticides and 
industrial chemicals, from wastewater (Darowna et al., 2014; Wijekoon et al., 2014a). Recently, TrOC 
removal has also been investigated by coupling an activated sludge based bioreactor to MD that achieved 
excellent (95-99%) TrOC retention (Wijekoon et al., 2014b). Since effective retention of TrOCs by the 
MD theoretically decouples organic retention time from hydraulic retention time of a bioreactor, the 
degradation of TrOCs is expected to improve due to prolonged contact time between the recalcitrant 
compounds and the microorganisms (Luo et al., 2014a). However, it was found that the biodegradation of 
resistant TrOCs, such as those containing strong electron withdrawing functional groups (EWGs), by the 
activated sludge in the MD-coupled bioreactor did not improve, and eventually these TrOCs accumulated 
in the bioreactor (Hai et al., 2014; Wijekoon et al., 2014b). Hence, to realize the full potential of a 
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combined biological - MD process, it is necessary to find the means to improve biodegradation of TrOCs 
retained in the bioreactor by the MD membrane. In this context, it is noteworthy that the oxidoreductase 
enzyme laccase (EC 1.10.3.2) can degrade TrOCs that are less susceptible to degradation by the activated 
sludge process (Cruz-Morató et al., 2014; Yang et al., 2013).  
Laccase can catalyze the degradation of a broad spectrum of pollutants including aromatic hydrocarbons, 
aliphatic amines and TrOCs by using dissolved oxygen as a co-substrate (Asif et al., 2017b; Hai et al., 
2007; Yang et al., 2013). However, its larger scale application is restricted by the lack of a reactor system, 
which can prevent washout of enzymes along with treated effluent. In a recent study, Asif et al. (2017c) 
combined an enzymatic bioreactor with the MD (MD - Enzymatic membrane bioreactor or MD-EMBR), 
which retained both laccase and the tested TrOCs (carbamazepine, sulfamethoxazole, diclofenac, atrazine 
and oxybenzone). During a short term (12 h) batch operation of the MD-EMBR (Asif et al., 2017c), 
degradation of the investigated TrOCs by laccase was found to improve significantly compared to that 
achieved by an activated sludge-based MD bioreactor (Wijekoon et al., 2014b). Furthermore, TrOC 
degradation by the MD-EMBR was better than those achieved by previously developed ultrafiltration 
(UF)-EMBRs, which retained laccase but not TrOCs (Asif et al., 2017c; Nguyen et al., 2016). Apparently, 
the effective retention of the TrOCs by the MD membrane also improved their biodegradation. The initial 
observations were promising but it is necessary to assess the performance of MD-EMBR for a wide range 
of TrOCs during continuous operation.  
This study aims to evaluate the performance of the MD-EMBR system for the degradation of a set of 30 
TrOCs with diverse physicochemical properties following their effective retention by the MD membrane. 
Redox mediators, which are low molecular weight substrates of laccase, can enhance enzymatic 
degradation (Yang et al., 2013). Thus, additionally, the effect of dosing two redox-mediators viz violuric 
acid (VA) and syringaldehyde (SA), separately and as a mixture, on TrOC degradation and laccase 
stability was investigated. Redox mediators can improve degradation but may increase the toxicity of the 
treated effluent (Ashe et al., 2016; Nguyen et al., 2016), therefore, the toxicity of the bioreactor media and 
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MD permeate (i.e., final effluent) to bacteria was monitored to clarify the applicability of this treatment 
process. Finally, during continuous operation, TrOC retention by MD can decrease over time due to 
‘membrane wetting’ or loss of hydrophobicity (Alkhudhiri et al., 2012; Duong et al., 2017). Accordingly, 
the effect of laccase and redox-mediators on the MD performance was also investigated.  
2. Materials and methods 
2.1. TrOCs, laccase and mediators 
A synthetic wastewater containing a mixture of 30 TrOCs in Milli-Q water was prepared for this study. 
These compounds were selected to represent different common classes of TrOCs, viz pharmaceutical and 
personal care products, industrial chemicals, steroid hormones and pesticides, which are commonly 
detected in different environmental systems (Luo et al., 2014b). A complete list along with their chemical 
structures appears in Supplementary Data. Relevant physicochemical properties of the selected TrOCs 
such as hydrophobicity (log D) and volatility (pKH) are given in Table 1. Analytical grade TrOCs were 
purchased from Sigma Aldrich (Australia). A stock solution (25 mg/L) containing the mixture of 30 
TrOCs was prepared in methanol, and kept in dark at -18 ºC prior to use.  
[Table 1] 
Laccase from genetically modified Aspergillus oryzae (Novozymes Australia Pty Ltd.) was used in this 
study. According to the supplier, the molecular weight of this laccase is 56 kDa. It has a purity of 
approximately 10% (w/w), density of 1.12 g/mL, and activity (measured using 2,6-dimethoxy phenol, 
DMP, as substrate) of 150,000 µM(DMP)/min. One of the main factors governing the laccase-catalyzed 
degradation of a substrate is the relative oxidation reduction potential (ORP) of that substrate and laccase 
(Yang et al., 2013). In this study, the ORP of the laccase, measured using an ORP meter (see section 
2.4.2), was 0.3 V. 
Two analytical grade natural redox-mediators, namely violuric acid (VA) and syringaldehyde (SA) 
(Sigma Aldrich, Australia), were used. A separate stock solution (50 mM) of each mediator was prepared 
in ultrapure Milli-Q water, and stored at 4 ºC in the dark. SA and VA produce highly reactive phenoxyl 
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and aminoxyl radicals, respectively. They can mediate TrOC degradation by following a hydrogen atom 
transfer pathway (Ashe et al., 2016; Asif et al., 2017b). The physicochemical properties of redox-
mediators are presented in Supplementary Data.   
2.2. The MD-EMBR System  
A laboratory scale MD-EMBR system was used comprising a glass enzymatic bioreactor (1.5 L) and an 
external direct contact membrane distillation (DCMD) module. A schematic of the setup is available in 
Supplementary Data. The enzymatic bioreactor was covered with aluminum foil and was placed in a 
water bath maintained at 30±0.2 
o
C using an immersion heating unit (Julabo, Germany). The enzymatic 
bioreactor was equipped with an air pump (ACO-002, Zhejiang Sensen Industry Co. Ltd., Zhejiang, 
China) to maintain the dissolved oxygen concentration at around 3 mg/L.  
The external DCMD module contained an acrylic glass membrane cell, two circulation pumps 
(Micropump Inc., USA) and a glass permeate tank. Feed and permeate flow channels were engraved on 
each block of the membrane cell. The length, width and height of each flow channel were 145, 95 and 3 
mm, respectively. The media from the glass enzymatic bioreactor and water from the permeate tank were 
passed through the membrane cell and then returned back to the enzymatic bioreactor and permeate tank, 
respectively. A chiller (SC100-A10, Thermo Scientific, USA) was used to regulate the temperature of the 
permeate tank at 10±0.1 
o
C. The permeate tank was also placed on a precision balance (Mettler Toledo 
Inc, USA) to monitor permeate flux. The recirculation flow rate of both feed and the distillate was 
controlled at 1 L/min (corresponding to a cross flow velocity of 9 cm/s) using two rotameters.  
A hydrophobic microporous flat-sheet polytetrafluoroethylene (PTFE) membrane (GE, Minnetonka, MN) 
was used in this study. The PTFE membrane had a nominal pore size of 0.2 µm, thickness of 175 µm, 
porosity of 70% and an active layer thickness of 5 µm (Nghiem & Cath, 2011).  
2.3. Experimental protocol 
After confirming the retention of laccase by the MD membrane, a series of experiments were conducted 
to investigate TrOC retention (by MD membrane) and enzymatic degradation with and without the 
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addition of mediators (i.e., SA and VA). The initial laccase activity and TrOC concentration in the 
enzymatic bioreactor of MD-EMBR was 95-100 µM(DMP)/min and 20 µg/L, respectively. It is noteworthy 
that laccase activity in the enzymatic bioreactors may gradually diminish due to various physicochemical 
and biological inhibitors such as shear stress caused by membrane filtration (Asif et al., 2017a). Hence, 
the laccase activity was maintained at 95-100 µM(DMP)/min by injecting a small dose of laccase (275 and 
400 µL per liter of reactor volume for laccase and laccase-mediator, respectively) every 12 h to sustain 
MD-EMBR operation.  
The MD-EMBR was first operated for a period of 60 h (i.e., 2× HRT) in a continuous mode (i.e., 
continuous withdrawal of treated effluent) without the addition of mediators. The enzymatic bioreactor 
was replenished with synthetic wastewater every time the water recovery reached 70% (i.e., 
approximately around every 24 h). Feed, bioreactor supernatant and treated effluent (i.e., MD-permeate) 
samples were collected after 30 and 60 h of MD-EMBR operation for TrOC quantification. The effect of 
individual mediators and SA-VA mixture on TrOC degradation was investigated in additional runs. A 
single dose of an individual redox-mediator (SA or VA at 0.5 mM) or their mixture (0.25 mM SA and 
0.25 mM VA) was added to the enzymatic bioreactor at the beginning of a run. Again, two sets of feed, 
supernatant and permeate samples for TrOC quantification were collected.  
2.4. Analytical methods 
2.4.1. TrOC analysis 
TrOCs were analyzed by solid phase extraction (SPE) and quantitative determination by a Shimadzu 
GC/MS (QP5000) system (Hai et al., 2011; Wijekoon et al., 2014b). TrOCs present in the feed, 
supernatant and permeate samples were extracted using 6 mL 200 mg Oasis HLB cartridges (Waters, 
Milford, MA, USA). The TrOC extraction procedure was as follows: (i) pre-conditioning of HLB 
cartridge with 5 mL dichloromethane and methanol solution (1:1 v/v), 5 mL methanol and 5 mL Milli-Q 
water; (ii) loading of acidified (pH 2-2.5) samples onto the cartridges at a flow rate of 1–4 mL/min; and 
(iii) drying of cartridges with nitrogen for 30 min. The TrOCs were subsequently eluted from the 
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cartridge using 5 mL of methanol followed by dichloromethane and methanol mixture (1:1 v/v) at a flow 
rate of 1–4 mL/min. The effluent was subsequently evaporated at 40 
o
C under a gentle stream of nitrogen. 
The residual after evaporation was re-dissolved in 200 µL methanol containing an internal standard (5 mg 
bisphenol A-d16) before its transfer into 1.5 mL vials. The mixture present in 1.5 mL vials was again 
evaporated under gentle stream of nitrogen. Finally, the extracts were derivatized by adding 100 µL of 
N,O-bis(trimethylsilyl)trifluoroacetamide (1% trimethylchlorosilane) and pyridine (dried with KOH 
solid), then heated on a heating block (60–70
 o
C) for 30 min. The derivatives were cooled to room 
temperature and analyzed using the Shimadzu QP5000 GC–MS (Shimadzu, Kyoto, Japan). The limit of 
detection (LOD) for this method is compound specific and ranged from 1-20 ng/L as listed in 
Supplementary Data. Removal efficiency by enzymatic reactor (R1) and MD-EMBR (R2) was calculated 
as shown in equation (1) and (2), respectively:   
 = 100	 × (1 −




) (1) 
 = 100	 × (1 −




) (2) 
Where, Cf, Csu and Cp are the concentration (ng/L) of a specific TrOC in the feed, supernatant and 
permeate, respectively. The enzymatic transformation/degradation was calculated as follows:  
Cf × Vf  = (Csu × Vsu) + (Cp × Vp) + biodegradation/biotransformation  (3) 
Where, Vf, Vsu and Vp represents the volume of feed, supernatant and permeate, respectively. 
2.4.2. Laccase activity, ORP, toxicity and contact angle 
Laccase activity and effluent toxicity were examined as described elsewhere (Nguyen et al., 2016). 
Enzymatic activity was determined by recording the change in absorbance at 468 nm due to the oxidation 
of 2,6-dimethoxyl phenol (DMP) in the presence of 100 mM sodium citrate (pH 4.5). Laccase activity 
expressed as µM(DMP)/min was then calculated using its molar extinction coefficient of 49.6/mM.cm. ORP 
was measured using an ORP meter (WP-80D dual pH-mV meter, Thermo Fisher Scientific, Australia).  
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Samples for toxicity analysis were collected from the enzymatic bioreactor and permeate tank at the end 
of each experiment. Toxicity, expressed as a relative toxicity unit (rTU), was analyzed by measuring the 
inhibition of luminescence in the naturally bioluminescent bacteria Photobacterium leiognathi using the 
BLT-Screen as previously described by van de Merwe and Leusch (2015).  
The contact angle of the membrane surface was measured using a Rame-Hart Goniometer (Model 250, 
Rame-Hart, Netcong, New Jersey, USA) using the standard sessile drop method, with Milli-Q water 
being used as the reference liquid (Duong et al., 2016).  
3. Results and discussion 
3.1. Overall TrOC removal by MD-EMBR 
Retention by the MD membrane and degradation in the enzymatic bioreactor are two major mechanisms 
for TrOC removal in the MD-EMBR system. TrOC retention/removal by the MD membrane is governed 
by the vapor pressure (indicated by Henry’s constant, H or, pKH = -log H; Table 1) and the water partition 
coefficient (log D; Table 1) of the target TrOC. In a stand-alone MD system, a low (<2.5) ‘pKH /log D’ 
ratio suggests poor removal of the target compound (Wijekoon et al., 2014a). By contrast, the MD 
membrane coupled to an activated sludge bioreactor may achieve high removal of the target compounds 
irrespective of their pKH /log D ratio. This is because a compound with a low pKH /log D ratio tends to be 
adsorbed on the bioreactor particles (Wijekoon et al., 2014b). Although the enzymatic bioreactor was free 
of any suspended particles that can potentially adsorb TrOCs, MD-EMBR still achieved 94 to over 99% 
removal for the 30 TrOCs tested (Figure 1). It is noteworthy that compared to their partial removal (54-
70%) in a stand-alone MD system (Wijekoon et al., 2014a), the permeate from the MD-EMBR in the 
current study achieved over 99% removal of some TrOCs including 4-tert-octylphenol (pKH /log D = 
0.98), octocrylene (pKH /log D = 1.21), 4-tert-butylphenol (pKH /log D = 1.51), benzophenone (pKH /log 
D = 1.83) and oxybenzone (pKH /log D = 2.1). This significant improvement can be attributed to the 
efficient degradation of these TrOCs by laccase in MD-EMBR as discussed in the following sections.  
[Figure 1] 
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3.2. TrOC degradation in MD-EMBR 
Laccase degrades a substrate via a radical-catalyzed mechanism. In this process, transfer of one electron 
from a substrate to laccase occurs, and molecular oxygen is reduced to water. Laccase can efficiently 
degrade phenolic pollutants i.e., substrates containing a hydroxyl (–OH) group attached to a benzene ring. 
On the other hand, non-phenolic pollutants are less amenable to laccase-catalyzed degradation (Asif et al., 
2017b; Yang et al., 2013). Therefore, degradation of phenolic and non-phenolic TrOCs are discussed 
separately.   
3.2.1. Degradation of phenolic TrOCs 
Of the 13 phenolic TrOCs tested (Figure 1), laccase achieved significant degradation (95-99%) of 10 
compounds including five steroid hormones, three industrial chemicals (bisphenol A, 4-tert-butylphenol 
and 4-tert-octylphenol) and two ingredients of personal care products (triclosan and oxybenzone). The 
observation of efficient enzymatic degradation of these TrOCs in MD-EMBR is consistent with the 
literature regarding previously developed enzymatic bioreactors. For example, Lloret et al. (2012) 
achieved 95-99% removal of two steroid hormones (estrone and 17β–estradiol) in a batch enzymatic 
bioreactor. Similarly, efficient degradation (>90%) of oxybenzone, bisphenol A, triclosan and 4-tert-
butylphenol has been achieved by batch or continuous flow enzymatic bioreactors (Margot et al., 2013; 
Nguyen et al., 2016).  
Notably, a reduced removal (20-35%) of three natural steroid hormones such as estrone, 17β-estradiol and 
estriol has been reported in continuous flow UF-EMBRs, as compared to that achieved by batch 
enzymatic bioreactor (Lloret et al., 2012; Nguyen et al., 2015). This was attributed to the sustained-TrOC 
loading in UF-EMBRs. In this study, degradation of estrone, 17β-estradiol and estriol was greater than 
99%, which indicates that effective retention of these TrOCs by the MD membrane facilitated their 
degradation by laccase in MD-EMBR.  
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Although phenolic TrOCs are especially amenable to laccase-catalyzed degradation, moderate 
degradation of a few phenolic compounds has been previously attributed to the presence of EWG(s) in 
their molecular structure (d’Acunzo et al., 2006). Due to the steric hindrance caused by the concomitant 
presence of an EWG, phenolic TrOCs cannot access the active sites of laccase for efficient degradation 
(d’Acunzo et al., 2006; Nguyen et al., 2016). In line with this, a moderate degradation (44-65%) was 
observed for three phenolic TrOCs, namely salicylic acid, pentachlorophenol and enterolactone in this 
study, which contain an EWG (i.e., carbonyl or halogen) in their molecule (Figure 1).  
3.2.2. Degradation of non-phenolic TrOCs 
Laccase can oxidize non-phenolic TrOCs, but the extent of the degradation may not be significant (Yang 
et al., 2013). In previous studies, two distinct trends were observed for the degradation of non-phenolic 
TrOCs by laccase: (i) poor removal (e.g., less than 5%) of those that only contain strong EWGs such as 
halogen (–X), amide (–CONR2) and carbonyl (–C=O); and (ii) moderate to high removal of those that 
contain both EWGs and electron donating functional groups (EDGs) such as amine (–NH2) or alkoxy (–
OR) (Asif et al., 2017a; Ji et al., 2016; Yang et al., 2013). In this study, benzophenone, octocrylene and 
amitriptyline were significantly degraded (>95%) by laccase. On the other hand, a moderate degradation 
(45-75%) was observed for the remaining non-phenolic TrOCs (Figure 1).   
Of particular interest is the enhanced degradation of pharmaceuticals and pesticides (containing strong 
EWGs) that were previously reported to be poorly (<10%) degraded by laccase in both batch and 
continuous flow enzymatic bioreactors (Margot et al., 2013; Nguyen et al., 2016). These TrOCs include 
ketoprofen (EWG carboxylic; 52% removal), clofibric acid (EWG halogen; 55% removal), 
carbamazepine (EWG amide; 62% removal), metronidazole (EWG nitro; 67% removal), atrazine (EWG 
halogen; 59% removal), fenoprop (EWG halogen, 48% removal) and N, N-Diethyl-meta-toluamide 
(DEET; EWG amide; 69% removal) (Figure 1). In a previous study, significantly improved degradation 
of recalcitrant TrOCs such as carbamazepine, atrazine and diclofenac was attributed to simultaneous 
adsorption of laccase and TrOCs on granular activated carbon which allowed prolonged close contact 
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between laccase and TrOCs (Nguyen et al., 2014b). Although our approach was different, the enhanced 
degradation of recalcitrant TrOCs in MD-EMBR can be ascribed to the increased contact time between 
laccase and TrOCs following their complete retention (95-99% removal) by the MD membrane.  
It is also noteworthy that TrOCs containing EDGs such as hydroxyl and amine (e.g., steroid hormones, 
bisphenol A and triclosan) can act as bi-functional substrates or redox-mediators (d’Acunzo et al., 2006; 
Hachi et al., 2017). Fragments of phenoxyl radicals or oxidative coupling agents (e.g., dimers) produced 
due to the oxidation of bi-functional substrates can facilitate the degradation of recalcitrant TrOCs via 
enzymatic and/or non-enzymatic reactions (e.g., polymerization or agglomeration). Indeed, Margot et al. 
(2013) reported significantly higher diclofenac removal in presence of  the phenolic TrOC bisphenol A 
compared to that observed for diclofenac as a single compound. Similarly, Nair et al. (2013) observed 
above 90% removal of diclofenac in a mixture containing bisphenol A, 17α–ethinylestradiol and 
diclofenac as compared to its 70% removal in absence of the phenolic TrOCs. In another study, Hachi et 
al. (2017) demonstrated that an oxidative coupling agent (i.e., dimer) produced due to the degradation of 
acetaminophen containing an EDG (i.e., amine) formed oligomers with carbamazepine. These oligomers 
were more susceptible to laccase catalyzed oxidation than the parent compound, which led to enhanced 
carbamazepine degradation (Hachi et al., 2017). Furthermore, in nature, laccase oxidizes the aromatic 
rings of lignin and produce phenoxyl radical, which are responsible for the degradation of non-phenolic 
components of lignin (Castro et al., 2003; d’Acunzo et al., 2006). Thus, there is a strong body of evidence 
of TrOCs containing EDGs working as redox mediators for enhancing degradation of non-phenolics, 
albeit from batch tests only. The synthetic wastewater used in this study contained a mixture of TrOCs 
containing EDGs and EWGs, as would be expected in practical wastewater conditions. These TrOCs were 
well retained by the MD component during the continuous operation of the MD-EMBR (see Section 3.1). 
Therefore, it is possible that radicals or oxidative coupling agents formed due to the oxidation of TrOCs 
containing hydroxyl and amine functional groups also contributed in achieving enhanced degradation (as 
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compared to that achieved by previously developed enzymatic bioreactors) of resistant TrOCs containing 
EWGs by the MD-EMBR. 
3.3. MD-EMBR performance with mediator addition  
As noted in Section 3.2, efficient degradation (95-99%) by MD-EMBR was observed for 13 out of the 30 
TrOCs investigated here, while the remaining TrOCs were moderately removed (44-75%). While these 
removal rates compare favorably with that in previous reports, two naturally occurring redox-mediators, 
namely SA and VA, were added to the EMBR separately and as a mixture in an attempt to further 
improve removal of the recalcitrant TrOCs.  
Oxidation of VA and SA by laccase produces highly reactive aminoxyl and phenoxyl radicals, 
respectively, that have higher ORP than laccase. Moreover, these radicals act as an electron shuttle 
between the substrate and laccase, thereby improving the degradation of the substrate i.e., target 
pollutants (Ashe et al., 2016). In a study by Weng et al. (2012), addition of SA increased the ORP of the 
enzyme solution, consequently improving the degradation of sulphonamide antibiotics. Similarly, an 
increase in ORP was accompanied by an improved degradation of atrazine, pentachlorophenol, naproxen 
and oxybenzone following the addition of VA at a concentration of 0.5-1 mM in a batch enzymatic 
bioreactor (Ashe et al., 2016). In the current study, the ORP of EMBR-media increased from 0.3 to 0.39 
and 0.45 V following the addition of SA and VA, respectively. This was accompanied by significant 
improvement in TrOC removal: an increase of 5-54% depending on the molecular structure of TrOCs and 
redox-mediator type as discussed below (Figure 2).  
[Figure 2] 
The performance of different mediators for enhanced TrOC degradation has been reported in only a few 
batch or UF-EMBR studies (Ashe et al., 2016; Lloret et al., 2013; Nguyen et al., 2016). In previous 
studies, a continuous supply of redox-mediator was required to sustain UF-EMBR operation, because UF 
membranes cannot retain redox-mediators (Nguyen et al., 2014a; Nguyen et al., 2016). A uniqueness of 
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this study is that it demonstrates the effect of the single dose of mediators on TrOC degradation following 
the complete retention of laccase, TrOCs and mediators by the MD membrane. SA and VA demonstrated 
substrate specific improvements in the degradation of TrOC that were moderately degraded by laccase-
only (Figure 1). Of the 17 moderately degraded TrOCs (Figure 1), the laccase-VA system achieved better 
degradation for six compounds namely, ketoprofen, gemfibrozil, naproxen, primidone, carbamazepine 
and pentachlorophenol. By contrast, the laccase-SA system performed best for four compounds; 
fenoprop, clofibric acid, propoxur and atrazine (Figure 2). Similar degradation efficiency was achieved by 
both SA and VA for the remaining TrOCs. A comparison of TrOC fate in laccase and laccase-mediator 
based MD-EMBR revealed that the molecular structures of TrOCs significantly influence the 
effectiveness of laccase-mediator systems (Figure 3).   
[Figure 3] 
3.4. Effect of mediator mixture on TrOC degradation 
Since in this study, SA and VA showed different patterns of TrOC-specific degradation-improvement 
(Figure 2), it was envisaged that a mediator-mixture would have further beneficial effects. Degradation of 
the phenolic TrOCs, which were already well removed by laccase-only, remained unaffected when a SA-
VA mixture was used. The whole set of data is provided in Supplementary Data.  However, compared to 
either SA-laccase or VA-laccase, the SA-VA-laccase system did not improve the degradation of any 
TrOCs (Figure 4). Furthermore, in comparison to TrOC degradation by laccase-only, the SA-VA-laccase 
system achieved somewhat reduced degradation of six pharmaceuticals, namely ketoprofen, naproxen, 
clofibric acid, primidone, carbamazepine and ibuprofen (Figure 4).  
The performance of mediator mixtures has rarely been studied for the removal of TrOCs. Previously, Jeon 
et al. (2008) observed in batch tests that vanillin and acetovanillone mixture did not improve the 
degradation of pentachlorophenol, while enhanced pentachlorophenol degradation was found by adding a 
mixture of 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) and vanillin or acetovanillone 
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(Jeon et al., 2008). It is possible that, in mixtures, some mediators can chemically interact with each other 
instead of acting as an electron shuttle for laccase. Moreover, simultaneous addition of some mediators 
can reversibly inhibit laccase, thereby inhibiting electron transfer between laccase and TrOCs (Dizhbite et 
al., 2004; Jeon et al., 2008). Indeed, laccase inactivation was significantly increased following the 
addition of SA-VA mixture (see section 3.5). The current work demonstrates for the first time through 
continuous operation of the MD-EMBR that although VA and SA outcompete many other mediators 
tested to date (Ashe et al., 2016), using them together may be counterproductive. Further studies to screen 
redox-mediators and their mixtures are recommended, but that is beyond the scope of the current study.  
 [Figure 4] 
3.5. Laccase stability in MD-EMBR 
Laccase activity in enzymatic bioreactors may be affected by various physicochemical and biological 
factors (Asif et al., 2017a; Purich, 2010). Transformation byproducts or charged metabolites formed 
following the degradation of TrOCs can block the active sites of the laccase. Moreover, hydraulic stress 
during MD-EMBR operation can also cause laccase inactivation (Lloret et al., 2013). Although some 
laccase inhibition was observed during continuous operation of the MD-EMBR (Figure 5), a stable 
operation could be sustained by reinjecting as little as 275-400 µL laccase solution per liter of reactor 
(working) volume every 12 h.  
[Figure 5] 
It may be noted that the MD membrane can theoretically retain all non-volatile compounds including 
redox-mediator derived highly active radicals along with laccase and TrOCs. The radicals enhance 
laccase-catalyzed TrOC degradation (Hachi et al., 2017), but can also instigate laccase inactivation. It has 
been suggested that the highly reactive radicals produced due to the oxidation of mediators can react with 
laccase, consequently converting them into non-productive complexes (Khlifi et al., 2010; Lloret et al., 
2013; Purich, 2010). Indeed, the extent of laccase inactivation increased during MD-EMBR operation 
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after mediator addition. This data is available in Supplementary Data section. The average laccase 
inactivation was 53±11% (no. of laccase injections, n=4) during MD-EMBR operation in absence of 
mediators, while the loss in laccase activity was 57±11, 62±16 and 80±12% (n=4) after the addition of a 
single dose of VA, SA and SA-VA mixture, respectively (Figure 5). To date higher laccase inactivation in 
presence of mediators has mostly been reported in small scale batch enzymatic bioreactors. For instance, 
Nguyen et al. (2014a) reported rapid laccase inactivation following the addition of SA at the tested 
concentrations of 0.1-1 mM in a batch enzymatic bioreactor. In another study, a complete loss of 
enzymatic activity was observed in a batch enzymatic bioreactor by adding VA at a concentration of 0.5 
mM (Ashe et al., 2016). In the current study, although laccase activity was significantly affected in the 
presence of redox-mediators, it was compensated for by the improvement in TrOC degradation (Figure 4).  
3.6. Permeate toxicity and flux  
Laccase-catalyzed degradation of TrOCs, particularly in the presence of mediators, produces reactive 
radicals and transformation products that may increase the toxicity of the treated effluent (Marco-Urrea et 
al., 2009; Nguyen et al., 2016). In this study, the overall bacterial toxicity of the media in the enzymatic 
bioreactor and MD-permeate (i.e., final effluent) was measured at the end of each EMBR run (Table 2). 
The media in the enzymatic bioreactor showed an overall toxicity of 5 ± 1, 14 ± 2, 65 ± 3 and 130 ± 12 
rTU (n=2) in presence of laccase, laccase-VA, laccase-SA and laccase-SA-VA, respectively. The 
observed increase in toxicity due to addition of VA and SA are consistent with previous studies (Ashe et 
al., 2016; Nguyen et al., 2016), however, this is the first study to report the toxicity in relation to mediator 
mixtures. A significantly increased toxicity following the addition of SA-VA mixture was observed. 
Despite the increase of toxicity in the enzymatic bioreactor, MD-EMBR permeate toxicity was below the 
limit of detection (i.e., rTU <1), evidencing that in addition to laccase and TrOCs, the MD system 
retained reactive radicals and transformation products, which cause bacterial toxicity. This is an added 
advantage of integrating a high retention membrane with an enzymatic bioreactor. 
[Table 2] 
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[Figure 6] 
In this study, a stable MD-permeate flux of approximately 4 L/m2.h was achieved in all experimental 
conditions irrespective of redox-mediator addition, which also indicates that membrane fouling did not 
occur. The flux achieved here is consistent with the applied temperature differential for MD operation. 
Permeate flux achieved in each MD-EMBR run is given in Supplementary Data. During prolonged 
continuous operation, the performance of the MD process can be affected by the loss of hydrophobicity of 
the MD membrane (Alkhudhiri et al., 2012; Duong et al., 2017). Therefore, the integrity of the MD 
membrane was assessed by measuring the contact angle of the membrane after each experiment. The 
contact angle i.e., the hydrophobicity was found to be not significantly affected (Figure 6), confirming the 
suitability of combining the MD membrane with the EMBR.  
4. Conclusions  
Efficient TrOC rejection by the MD membrane appeared to be beneficial for enhanced degradation of 
recalcitrant TrOCs. Addition of single redox-mediators, syringaldehyde (SA) and violuric acid (VA), 
significantly improved the degradation of those TrOCs that were moderately degraded by laccase. Despite 
the compound-specific improvement observed following the separate addition of SA and VA, a mixture 
of SA-VA was not effective for TrOC degradation. A mediator-specific increase in the toxicity of 
bioreactor media was observed, but no toxicity was detected in the membrane permeate. MD-EMBR 
operation was stable during all experiments, and membrane wetting or fouling was not observed.     
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Figure Captions 
Figure 1. Overall removal and enzymatic degradation of 30 TrOCs in MD-EMBR after 60 h of operation 
(i.e., 2×HRT). Operating conditions for MD-EMBR: The initial TrOC concentration and laccase activity 
was 20 µg/L and 95-100 µM(DMP)/min, respectively; temperature of the enzymatic bioreactor and the 
permeate tank was kept at 30 and 10 ºC; and cross-flow rate of water from enzymatic bioreactor and 
distillate was 1 L/min (corresponding to cross-flow velocity of 9 cm/s). Data presented as 
average±standard deviation (n=4).  
Figure 2. Enzymatic degradation of 30 TrOCs following the addition of two redox-mediators viz SA and 
VA separately at 0.5 mM in MD-EMBR. Data presented as average±standard deviation (n=4).  
Figure 3. Fate of TrOCs during MD-EMBR operation with and without the addition of redox-mediators.  
Figure 4. Effect of individual mediators and their mixture on the degradation of selected non-phenolic 
TrOCs showing reduced performance when mediator mixture was used. Data presented as 
average±standard deviation (n=4). Effect of mediator mixture (i.e., SA and VA) on all the tested TrOCs 
(i.e., phenolic and non-phenolic) is shown in Supplementary Data.  
Figure 5. Oxidation reduction potential (ORP) and laccase inactivation percentage with and without the 
addition of redox-mediators. Data presented as average±standard deviation (n=2 for ORP; and n=5 for 
laccase inactivation). Time course of enzymatic activity during all experiments is given in Supplementary 
Data. 
Figure 6. Contact angle of the membrane before and after using it for EMBR operation. Error 
bars represent the standard deviation of three repeated measurements. 
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List of Tables 
Table 1: Physicochemical properties of TrOCs selected for this study  
TrOCs Chemical Formula 
Molecular 
Weight 
Log D 
at 
pH=7 
Water 
Solubility 
at 25
o
C 
Vapor 
Pressure 
pKH at 
pH 7 
  g/mole  mg/L  (mmHg)  
Primidone C12H14N2O 218.25 0.83 1500 6.08 × 10
-11 13.93 
Ketoprofen C16H14O3 254.28 0.19 554,000 3.32 × 10
-8 13.70 
Naproxen C14H14O3 230.26 0.73 435,000 3.01 × 10
-7
 12.68 
Gemfibrozil C15H22O3 250.33 2.07 263,000 6.13 × 10 
-7 12.11 
Metronidazole C6H9N3O3 171.15 -0.14 29,000 2.67 × 10
-7 11.68 
Diclofenac C14H11Cl2NO2 296.15 1.77 20,000 1.59 × 10
-7 11.51 
Fenoprop C9H7Cl3O3 269.51 -0.13 230,000 2.13 × 10
-6 11.48 
Ibuprofen C13H18O2 206.28 0.94 928,000 1.39 × 10
-4
 10.39 
Ametryn C9H17N5S 27.33 2.97 140 1.72 × 10
-6
 9.35 
Clofibric acid C10H11ClO3 214.65 -1.06 100,000 1.03 × 10
-4
 9.54 
Carbamazepine C15H12N2O  236.27 1.89 220 5.78 × 10
-7
 9.09 
Octocrylene C24H27N 361.48 6.89 0.36 2.56 × 10
-9
 8.47 
Amitriptyline C20H23N 277.40 2.28 83 1.50 × 10
-6
 8.18 
Atrazine C8H14ClN5 215.68 2.64 69 1.27 × 10
-5
 7.28 
Propoxur  C11H15NO3 209.24 1.54 800 1.53 × 10
-3
 6.28 
Benzophenone C13H10O 182.22 3.21 150 8.23 × 10
-4
 5.88 
DEET C12H17NO 191.3 2.42 1000 5.6 × 10
-3
 5.85 
Enterolactone C18H18O4 288.38 2.53 200 3.29 × 10
-13
 15.20 
Estriol C18H24O3 298.33 1.89 32 1.34 × 10
-9
 10.78 
17α– 
Ethinylestradiol  
C20H24O2 269.40 4.11 3.9 3.74 × 10
-9
 9.47 
Oxybenzone C14H12O3 228.24 3.89 2700 5.26 × 10
-6 9.23 
Estrone C18H22O2 270.37 3.62 5.9 1.54 × 10
-8
 9.03 
17β–Estradiol C18H24O2 272.38 4.15 3 9.82 × 10
-9
 8.93 
17β-Estradiol-17-
acetate 
C20H26O3 314.42 5.11 1.9 9.88 ×10
-9
 8.67 
Bisphenol A C15H16O2 228.29 3.64 73 5.34 × 10
-7
 8.66 
Salicylic acid C7H6O3 138.12 -1.13 2240 8.2 × 10
-5
 8.18 
Pentachlorophenol C6HCl5O 266.34 2.85 4800 3.49 × 10
-4
 7.59 
Triclosan C12H7Cl3O2 289.54 5.28 19 3.26 ×10
-5
 6.18 
4-tert-Butylphenol  C10H14O 150.22 3.40 1000 0.0361 5.15 
4-tert-Octylphenol  C14H22O 206.32 5.18 62 1.98 × 10
-3
 5.06 
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Table 2. Toxicity caused by different combinations of laccase, TrOCs and mediators (n=2). The limit of 
detection of the toxicity assay was 10% inhibition of luminescence (i.e., at the tested concentrations, 1 
rTU).  
Reaction media Toxicity in enzymatic 
bioreactor (rTU) 
Toxicity of the 
permeate (rTU) 
TrOCs + Laccase  5 ± 1 <1 
TrOCs + Laccase + VA (0.5 mM) 14 ± 2 <1 
TrOCs + Laccase + SA (0.5 mM) 65 ± 3 <1 
TrOCs + Laccase + SA (0.25 mM) + VA (0.25 mM) 130 ± 12 <1 
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Table S1: Physicochemical properties of the selected trace organic contaminants (TrOCs) 
Category 
Compound 
(Formula) 
(CAS number) 
Molecular 
weight 
(g/mol) 
Log 
KOW
a 
Log D 
(pH 7) 
a
 
Dissociati
on 
constant 
( pKa)
 a 
Limit of 
detection 
(ng/L)
b 
Chemical structure 
P
h
ar
m
a
ce
u
ti
ca
ls
 
Ibuprofen 
(C13H18O2) 
(5687-27-1) 
206.28 
3.50 ± 
0.23 
0.94 
4.41 ± 
0.10 
20 
 
 Naproxen 
(C14H14O3) 
(22204-53-1) 
230.26 
2.88 ± 
0.24 
0.73 
4.84 ± 
0.30 
1 
 
Ketoprofen 
(C16H14O3) 
(22071-15-4) 
254.28 
2.91 ± 
0.33 
0.19  
4.23 ± 
0.10 
20 
 
Diclofenac 
(C14H11Cl2NO2) 
(15307-86-5) 
296.15 
4.55 ± 
0.57 
1.77  
4.18 ± 
0.10 
-2.26 ± 
0.50 
 
5 
 
Primidone 
(C12H14N2O2) 
(125-33-7) 
218.25 
0.83 ± 
0.50 
0.83 
12.26 ± 
0.40 
-1.07 ± 
0.40 
10 
 
Carbamazepine 
(C15H12N2O) 
(298-46-4) 
236.27 
1.89 ± 
0.59 
1.89 
13.94 ± 
0.20 
-0.49 ± 
0.20 
10 
 
Salicylic acid 
(C7H6O3) 
(69-72-7) 
138.12 
2.01 ± 
0.25 
-1.13 
3.01 ± 
0.10 
1 
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Metronidazole 
(C6H9N3O3) 
(443-48-1) 
171.15 
-0.14 ± 
0.30 
-0.14 
14.44 ± 
0.10 
2.58 ± 
0.34 
20 
 
Gemfibrozil 
(C15H22O3) 
(25812-30-0) 
250.33 
4.30 ± 
0.32 
2.07 4.75 1 
 
Amitriptyline 
C20 H23 N 
(50-48-6) 
277.40 
4.40±0.
26 
2.28 9.18±0.28 1 
 
P
er
so
n
al
 c
ar
e 
p
ro
d
u
ct
s 
Triclosan  
(C12H7Cl3O2) 
(3380-34-5) 
289.54 
5.34 ± 
0.79 
5.28 
7.80 ± 
0.35 
1 
 
Benzophenone 
C13 H10O 
(119-61-9) 
182.22 
3.21 ± 
0.29 
3.21 
- 
 
5 
 
Oxybenzone 
C14 H12 O3 
(131-57-7) 
228.24 
3.99±0.
36 
3.89 7.56±0.35 5 
 
Octocrylene 
C24 H27 N O2 
(6197-30-4) 
361.48 
6.89±0.
33  
6.89 - 10 
 
Page 33 of 40 
 
P
es
ti
ci
d
es
 
Fenoprop 
(C9H7Cl3O3) 
(93-72-1) 
269.51 
3.45 ± 
0.37 
-0.13 2.93 20 
 
Pentachloro-
phenol 
(C6HCl5O) 
(87-86-5) 
266.34 
5.12 ± 
0.36 
2.85 
4.68 ± 
0.33 
1 
 
Atrazine 
(C8H14ClN5) 
(1912-24-9) 
215.68 
2.636±0.
205 
2.64 2.27±0.10 10 
 
Propoxur 
(C11H15NO3) 
(114-26-1) 
209.24 
1.538±0.
229 
1.54 
12.28±0.4
6 
-
1.49±0.70 
1 
 
Ametryn 
(C9H17N5S) 
(843-12-8) 
 
227.33 
2.967± 
0.12 
2.97 3.71±0.41 10 
 
Clofibric acid  
(C10H11ClO3) 
(882-09-7) 
214.65 
2.425±0.
273 
-1.06 3.18 ±0.10 1 
 
 
DEET 
(C12H17NO) 
(134-62-3) 
 
191.27 
2.42 ± 
0.23 
2.42 
-1.37 ± 
0.7 
1 
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In
d
u
st
ri
al
 c
h
em
ic
al
s 
 
4-tert-
butylphenol 
(C10H14O) 
(98-54-4) 
150.22 
3.39 ± 
0.21 
3.40 
10.13 ± 
0.13 
1 
 
4-tert-
octylphenol 
(C14H22O) 
(140-66-9) 
206.32 
5.18 ± 
0.20 
5.18 
10.15 ± 
0.15 
1 
 
Bisphenol A 
(C15H16O2) 
(80-05-7) 
228.29 
3.64 ± 
0.23 
3.64 
10.29 ± 
0.10 
1 
 
S
te
ro
id
 h
o
rm
o
n
es
 
Estrone 
(C18H22O2) 
(53-16-7) 
270.37 
3.62 ± 
0.37 
3.62 
10.25 ± 
0.40 
5 
 
17β-estradiol 
(C18H24O2) 
(50-28-2) 
272.38 
4.15 ± 
0.26 
4.15 10.27 5 
 
17β-estradiol 17–
acetate 
(C20H26O3) 
(1743-60-8) 
314.42 
5.11 ± 
0.28 
5.11 
10.26 ± 
0.60 
5 
 
 
17α - 
ethinylestradiol 
(C20H24O2) 
(57-63-6) 
 
269.40 
4.10 ± 
0.31 
4.11 
10.24 ± 
0.60 
10 
 
Estriol (E3) 
(C18H24O3) 
(50-27-1) 
288.38 
2.53 ± 
0.28 
2.53 
10.25 ± 
0.70 
10 
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P
h
y
to
es
tr
o
g
e
n
s Enterolactone 
C18 H18 O4 
(78473-71-9) 
298.33 
1.89± 
0.37 
1.89 9.93± 0.10 10 
 
 
a
 Source: SciFinder database  https://scifinder.cas.org/scifinder/view/scifinder/scifinderExplore.jsf 
Log D is logarithm of the distribution coefficient which is the ratio of the sum of concentrations of all forms of the 
compound (ionised and unionised) in octanol and water at a given pH. 
b
Limit of detection (LOD) of the compounds during GC-MS analysis as described in Section 2.5.2. LOD is defined 
as the concentration of an analyte giving a signal to noise (S/N) ratio greater than 3. The limit of reporting was 
determined using an S/N ration of greater than 10.  
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Table S2. Properties of the selected redox-mediators  
 
Redox mediator 
Molecular 
weight 
Purity Type 
Free radical 
generated 
Oxidation 
mechanism 
Natural/ 
synthetic 
Chemical structure 
Syringaldehyde 
(SA) 
182.17 g/mole >98% C6H4(OH)(OCH3) 
C6H5O* 
Phenoxyl 
Hydrogen atom 
transfer (HAT) 
Natural 
 
Violuric acid (VA) 175.10 g/mole >98% N – OH 
=N – O* 
Aminoxyl 
Hydrogen atom 
transfer (HAT) 
Natural 
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Figure S3. Lab-scale membrane distillation – enzymatic membrane bioreactor (MD-EMBR)  
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Figure S4. Comparison of the degradation capacity of laccase, SA, VA and SA-VA mixture.  
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Figure S5. Enzymatic activity profiles with and without the addition of redox mediator(s).  
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Figure S6. Permeate flux obtained during the operation of enzymatic membrane distillation 
(MD-EMR) with and without the addition of mediators. Feed and distillate temperature were 
controlled at 30 and 10 °C, respectively during all experiments. The cross-flow rate of both feed 
and distillate side was set at 1 L/min (corresponding to a cross-flow velocity of 9 cm/s).  
